Related Experiment Video
Updated: May 17, 2026
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes
1Department of Cardiothoracic Surgery, Shanghai 10th People's Hospital, Shanghai, China.
European Review for Medical and Pharmacological Sciences
|November 1, 2012
Summary
This study identified key genes like EDNRB and ADRB2 involved in lung adenocarcinoma (LAC) progression. Bioinformatics analysis revealed potential pathways, paving the way for new diagnostic and therapeutic strategies in LAC.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Lung adenocarcinoma (LAC) is the most common lung cancer subtype with increasing global incidence.
- Existing molecular markers for LAC prediction are insufficient, necessitating the discovery of novel prognostic markers.
- Understanding the underlying mechanisms of LAC progression requires further investigation into potential molecular targets.
Purpose of the Study:
- To identify a set of discriminating genes for the characterization of lung adenocarcinoma.
- To predict the response to treatment in LAC patients using molecular markers.
- To elucidate novel target genes and pathways involved in LAC pathogenicity.
Main Methods:
- Bioinformatics analysis was employed to merge and analyze two LAC datasets (GSE2514 and GSE7670).
- Graph clustering methods were utilized to identify key genes and pathways associated with LAC.
- Gene expression data was analyzed to pinpoint potential molecular markers and their functional roles.
Main Results:
- Several genes, including EDNRB, ADRB2, S1PR1, P2RY14, LEPR, GHR, PPM1D, and GADD45B, demonstrated high relevance to LAC.
- Potential involvement of EDNRB, ADRB2, S1PR1, P2RY14, LEPR, and GHR in LAC was linked to Neuroactive ligand-receptor interactions.
- PPM1D and GADD45B were implicated in LAC through the p53 signaling pathway, with some findings supported by prior research.
Conclusions:
- Bioinformatics analysis combined with graph clustering is effective for identifying potential molecular markers in LAC.
- The study identified novel candidate genes (e.g., EDNRB, P2RY14, LEPR) for LAC, warranting further investigation.
- Experimental validation is crucial to confirm the identified molecular markers and their functional roles in lung adenocarcinoma.
